Ann: CardieX Engages MEDL Mobile for App SaaS & Cloud Development, page-4

IMO this is the best announcement that he Company have put out in a long time. Change in business model to drive SAAS, and an app to link with wearables that will inform Drs and patients with valuable data. CEO completely misjudged approach by being on HC and probably learned his lesson. This is very much in the PCK/RAP category of Companies.

These things always take a long time and they are talking Q3 2021 launch of new cBPM devices and software development and launch to coincide

Price has been hammered, its found a bottom, and if you have a long term view, this would be a very good price to get in at and stick them away for 2 years. ( not financial advice - my opinion)

I find it intriguing that they say Q3 launch 2021 and they will be trying bloody hard to meet that. Their CDXO 5c options expire Nov 21. That's what's driving the launch date. So at 2.8c, if the shares hit 5c that's 72% return. Worth the wait IMO